Total Payments
$4,125
2024 Payments
$379.62
Companies
15
Transactions
75
Medicare Patients
3,022
Medicare Billing
$177,103
Payment Breakdown by Category
Food & Beverage$4,125 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,125 | 75 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,410 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $290.38 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $276.67 | 4 | $0 (2018) |
| Lilly USA, LLC | $233.85 | 2 | $0 (2023) |
| Dexcom, Inc. | $230.69 | 2 | $0 (2023) |
| Merge Healthcare Incorporated | $150.10 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2018) |
| Celgene Corporation | $117.34 | 1 | $0 (2019) |
| Edwards Lifesciences Corporation | $94.86 | 1 | $0 (2024) |
| Boston Scientific Corporation | $91.91 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $379.62 | 4 | ABBVIE INC. ($192.85) |
| 2023 | $247.85 | 3 | Dexcom, Inc. ($116.70) |
| 2022 | $1,158 | 19 | ABBVIE INC. ($705.68) |
| 2021 | $493.76 | 10 | AbbVie Inc. ($475.90) |
| 2020 | $98.85 | 3 | AbbVie Inc. ($98.85) |
| 2019 | $768.94 | 18 | AbbVie, Inc. ($590.46) |
| 2018 | $484.80 | 11 | AbbVie, Inc. ($239.83) |
| 2017 | $492.76 | 7 | Novartis Pharmaceuticals Corporation ($261.50) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $52.71 | General |
| 03/29/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $49.09 | General |
| 03/28/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $35.80 | General |
| 03/06/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.97 | General |
| 02/28/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $68.08 | General |
| Category: Virology | ||||||
| 02/09/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $36.99 | General |
| 01/16/2019 | AbbVie, Inc. | Viekira Pak (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: Virology | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $51.68 | General |
| 09/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Immunology | ||||||
| 08/01/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Endocrinology | ||||||
| 06/14/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/31/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $55.34 | General |
| Category: Immunology | ||||||
| 05/29/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes Care | ||||||
| 04/12/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $67.02 | General |
| Category: Immunology | ||||||
| 02/03/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/01/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $58.97 | General |
| Category: Immunology | ||||||
| 01/25/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $62.87 | General |
| Category: Immunology | ||||||
| 06/20/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Immunology | ||||||
| 06/15/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/05/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $119.28 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 717 | 1,067 | $183,082 | $40,559 |
| 2022 | 15 | 814 | 1,120 | $180,265 | $37,796 |
| 2021 | 9 | 712 | 998 | $161,857 | $50,149 |
| 2020 | 13 | 779 | 1,147 | $180,558 | $48,600 |
Total Patients
3,022
Total Services
4,332
Medicare Billing
$177,103
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 85 | $595.00 | $247.59 | 41.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 24 | $840.00 | $201.94 | 24.0% |
| 91312 | Coronavirus vaccine 13 | Office | 2022 | 17 | 17 | $0.17 | $0.17 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 326 | $73,024 | $16,641 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 129 | 129 | $31,089 | $16,159 | 52.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 107 | 107 | $14,445 | $7,108 | 49.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 155 | $24,490 | $5,379 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 110 | 110 | $5,610 | $1,730 | 30.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 24 | 31 | $3,193 | $1,054 | 33.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 30 | 30 | $4,860 | $1,046 | 21.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 81 | $4,131 | $743.40 | 18.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 29 | 29 | $1,015 | $288.34 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 123 | 123 | $29,643 | $13,465 | 45.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 155 | 266 | $59,584 | $11,328 | 19.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 153 | 307 | $47,610 | $8,344 | 17.5% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 92 | 93 | $12,163 | $5,534 | 45.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 21 | 21 | $5,292 | $2,342 | 44.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 12 | 12 | $5,748 | $2,223 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 100 | 101 | $5,151 | $1,593 | 30.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 107 | $5,457 | $997.04 | 18.3% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 24 | 29 | $2,987 | $922.98 | 30.9% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 21 | 21 | $3,402 | $757.92 | 22.3% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 12 | 12 | $1,332 | $403.07 | 30.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 28 | 33 | $1,155 | $359.74 | 31.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 22 | 22 | $1,034 | $328.82 | 31.8% |
About Dr. Thomas Mihelich, MD
Dr. Thomas Mihelich, MD is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538193214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Mihelich, MD has received a total of $4,125 in payments from pharmaceutical and medical device companies, with $379.62 received in 2024. These payments were reported across 75 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,125).
As a Medicare-enrolled provider, Mihelich has provided services to 3,022 Medicare beneficiaries, totaling 4,332 services with total Medicare billing of $177,103. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tulsa, OK
- Active Since 07/10/2006
- Last Updated 03/09/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538193214
Products in Payments
- Humira (Biological) $569.46
- ENTRESTO (Drug) $276.67
- HUMIRA (Biological) $267.66
- MOUNJARO (Drug) $233.85
- FARXIGA (Drug) $185.02
- Software (Device) $150.10
- STEGLATRO (Drug) $125.00
- Otezla (Drug) $117.34
- DEXCOM G7 GSS (161) (Medical Supply) $116.70
- Dexcom G6 Transmitter (Medical Supply) $113.99
- Mavyret (Drug) $68.08
- Kerendia (Drug) $35.55
- Orilissa (Drug) $32.18
- Viekira Pak (Drug) $28.07
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $22.00
- RELISTOR (Drug) $17.86
- JARDIANCE (Drug) $14.51
- EVENITY (Biological) $14.09
- BYDUREON (Drug) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Jesse Richards, D.o, D.O
Internal Medicine — Payments: $147,415
Internal Medicine $147,415
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876